Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Bladder Cancer. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.


Journal Scan / Research · January 16, 2023

Prognostic Value of the Systemic Immune–Inflammation Index and the Preoperative Systemic Immune–Inflammation Index in Patients With NMIBC Receiving BCG Therapy

Clinical Genitourinary Cancer


Additional Info

Disclosure statements are available on the authors' profiles:

Clinical Genitourinary Cancer
Systemic Immune-inflammation Index (SII) During Induction has Higher Predictive Value Than Preoperative SII in Non-muscle-invasive Bladder Cancer Patients Receiving Intravesical Bacillus Calmette -Guerin
Clin Genitourin Cancer 2022 Nov 20;[EPub Ahead of Print], L Deng-Xiong, Y Qing-Xin, F De-Chao, Z Fa-Cai, W Rui-Cheng, X Shi, P Han

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading